SeaSpine 2017 revenue hits nearly $132M — 14 insights

SeaSpine reported its fourth quarter and full-year 2017 financial results.

Advertisement

Here are eight takeaways from the company’s fourth quarter.

 

1. The company saw revenue of $34 million, reflecting a 4.5 percent year-over-year increase.

 

2. In the U.S., SeaSpine reported revenue of $31.2 million, a 4.8 percent year-over-year jump.

 

3. Orthobiologics revenue reached $18.1 million, an 8.8 percent year-over-year boost.

 

4. SeaSpine reported spinal implants revenue reached $15.9 million, which didn’t register a significant change year over year.

 

5. The company saw $2.8 million in international revenue, which is a 1 percent year-over-year increase.

 

6. The company’s gross margin was 63.3 percent, compared to 58.6 percent in the fourth quarter of 2016.

 

7. SeaSpine reported net loss of $7.5 million, compared to $9.8 million in the same period the year prior.

 

8. The company had $10.8 million in cash and cash equivalents on Dec. 31, 2017.

 

The following reflects the company’s full-year 2017 financial results.

 

9. Full-year revenue reached $131.8 million, a 2.3 percent jump over 2016.

 

10. U.S. revenue hit $118.4 million, a 1.4 percent boost compared to 2016.

 

11. The orthobiologics revenue reached $69.1 million, a 4.4 percent jump from the year prior.

 

12. Spinal implant revenue totaled $62.7 million, a stagnant result compared to the year prior.

 

13. SeaSpine’s gross margin was 60.7 percent in 2017.

 

14. The company had a net loss of $32.1 million, compared to $43.2 million in 2016.

 

SeaSpine anticipates full-year 2018 revenue to land between $135 million and $139 million.

More articles on devices:
Wright Medical reports $217.6M in Q4 sales: 6 takeaways
DePuy Synthes, Stryker, NuVasive & more: 12 device company notes
Ortho Sales Partners forming orthopedics and spine divisions, announces two executive additions: 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.